MAPT and Alzheimer disease: EWAS conducted by Marzi et al. investigated H3K27 histone acetylation in postmortem AD brain samples and identified 4162 differentially acetylated peaks, of which many were located in genes implicated in AD pathology or AD genetic risk variants (APP, PSEN1, PSEN2, and MAPT) [118].